Pfizer buys Washington-based biotech developer to improve access to cancer treatments

Seagen, based in Bothell, is a biotech company that specializes in working with anti-body drug conjugate technology. Its key products use lab-made proteins called monoclonal antibodies that seek out cancer cells to help deliver a cancer-killing drug while sparing surrounding tissue.